Age, therapeutic “milieu” and clinical outcome in depressive patients treated with viloxazine: A study with plasma levels
- 1 January 1986
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 10 (1) , 67-75
- https://doi.org/10.1016/0278-5846(86)90045-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Age-related differences in kinetics and side-effects of viloxazine in man and their clinical implicationsPsychopharmacology, 1983
- Depression in old age.BMJ, 1983
- VILOXAZINE HCL IN THE TREATMENT OF ENDOGENOUS-DEPRESSION - A STANDARD (IMIPRAMINE) CONTROLLED CLINICAL-STUDY1982
- Clinical Pharmacology of Viloxazine HydrochloridePharmacopsychiatry, 1981
- Long-Term Monitoring of Tricyclic Antidepressant Plasma ConcentrationsThe British Journal of Psychiatry, 1980
- Multicentre Study with Viloxazine (Vivalan®) in Depressed PatientsInternational Pharmacopsychiatry, 1980
- A Double Blind Comparative Trial of Viloxazine and Amitriptyline in Patients Suffering from Endogenous DepressionAustralian & New Zealand Journal of Psychiatry, 1979
- ViloxazineDrugs, 1977